CZR analyst scorecard
45 rating actions on CZR in the last 12 months. Of 70 price targets that resolved, 8 were reached while they stood, 59 were replaced by the same firm first, and 3 fell short at their deadline. Ratings: 49% Buy-type, 51% Hold-type, 0% Sell-type. Consensus target $31, 8% above the last close.
Checked through 2026-10-29 · last close $29.07 (2026-10-29). Rebuilt every morning.
What the Holds say: 23 Hold-type ratings on CZR in the last 12 months carried a median target +6% from the price on the day; 17% sat below it.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| Macquarie | Neutral | 2026-07-29 | $31 | 0 | 8 | 8 | 0 of 1 |
| Stifel | Hold | 2026-06-15 | $31 | 0 | 7 | 7 | 0 of 1 |
| Truist Securities | Hold | 2026-05-29 | $31 | 1 | 7 | 8 | 0 of 1 |
| JPMorgan | Neutral | 2026-05-29 | $31 | 0 | 7 | 7 | 0 of 1 |
| Morgan Stanley | Equal-Weight | 2026-04-08 | $34 | 2 | 4 | 6 | — |
| Wells Fargo | Equal-Weight | 2026-06-02 | $31 | 1 | 3 | 4 | 0 of 1 |
| Citizens | Market Outperform | 2026-04-29 | $35 | 0 | 2 | 2 | 1 of 1 |
| TD Cowen | Hold | 2026-07-29 | $31 | 0 | 2 | 2 | 0 of 1 |
| Barclays | Equal-Weight | 2026-07-09 | $31 | 0 | 7 | 7 | 0 of 1 |
| Goldman Sachs | Neutral | 2025-12-15 | $24 | 0 | 2 | 2 | — |
| Susquehanna | Neutral | 2026-05-29 | $31 | 1 | 3 | 4 | — |
| Citigroup | Neutral | 2026-04-16 | $30 | 2 | 0 | 2 | — |
| Jefferies | Hold | 2026-04-06 | $26 | 1 | 1 | 2 | — |
| Deutsche Bank | Hold | 2026-06-01 | $31 | — | — | 0 | — |
| CBRE | Hold | 2026-05-29 | $31 | — | — | 0 | — |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor CZR carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-07-29 | TD Cowen | Buy → Hold | downgrade | $29.77 | $31 | within 5% of price when set | -0.2% |
| 2026-07-29 | Macquarie | Neutral | maintained | $29.77 | $31 | within 5% of price when set | -0.2% |
| 2026-07-09 | Barclays | Overweight → Equal-Weight | downgrade | $29.77 | $31 | within 5% of price when set | +1.1% |
| 2026-06-15 | Stifel | Buy → Hold | downgrade | $29.50 | $31 | running to 2027-06-15 | +6.1% |
| 2026-06-02 | Wells Fargo | Equal-Weight | maintained | $29.22 | $31 | running to 2027-06-02 | +3.0% |
| 2026-06-01 | Macquarie | Outperform → Neutral | downgrade | $29.15 | $31 | running to 2027-06-01 | +2.7% |
| 2026-06-01 | Deutsche Bank | Buy → Hold | downgrade | $29.15 | $31 | running to 2027-06-01 | +2.7% |
| 2026-05-29 | CBRE | Buy → Hold | downgrade | $29.05 | $31 | running to 2027-05-29 | +6.1% |
| 2026-05-29 | Truist Securities | Buy → Hold | downgrade | $29.05 | $31 | running to 2027-05-29 | +6.1% |
| 2026-05-29 | Susquehanna | Positive → Neutral | downgrade | $29.05 | $31 | running to 2027-05-29 | +6.1% |
| 2026-05-29 | JPMorgan | Overweight → Neutral | downgrade | $29.05 | $31 | running to 2027-05-29 | +6.1% |
| 2026-05-28 | Macquarie | Outperform | maintained | $29.08 | $35 | replaced 2026-06-01, new $31 | +6.5% |
| 2026-05-19 | Macquarie | Outperform | maintained | $27.50 | $35 | replaced 2026-06-01, new $31 | +1.0% |
| 2026-04-29 | Macquarie | Outperform | maintained | $27.38 | $34 | replaced 2026-05-19, new $35 | +7.4% |
| 2026-04-29 | Citizens | Market Outperform | maintained | $27.38 | $35 | running to 2027-04-29 | +7.4% |
| 2026-04-29 | Wells Fargo | Equal-Weight | maintained | $27.38 | $26 | reached 2026-05-12 | +7.4% |
| 2026-04-29 | Susquehanna | Positive | maintained | $27.38 | $34 | replaced 2026-05-29, new $31 | +7.4% |
| 2026-04-29 | Stifel | Buy | maintained | $27.38 | $35 | replaced 2026-06-15, new $31 | +7.4% |
| 2026-04-21 | Truist Securities | Buy | maintained | $27.64 | $32 | replaced 2026-05-29, new $31 | +3.3% |
| 2026-04-16 | JPMorgan | Overweight | maintained | $27.68 | $35 | replaced 2026-05-29, new $31 | +1.3% |
| 2026-04-16 | Citigroup | Neutral | maintained | $27.68 | $30 | reached 2026-06-25 | +1.3% |
| 2026-04-16 | Wells Fargo | Equal-Weight | maintained | $27.68 | $24 | replaced 2026-04-29, new $26 | +1.3% |
| 2026-04-08 | Morgan Stanley | Equal-Weight | maintained | $26.85 | $34 | running to 2027-10-08 | +4.2% |
| 2026-04-06 | Jefferies | Hold | maintained | $26.70 | $26 | within 5% of price when set | +1.1% |
| 2026-03-12 | Morgan Stanley | Equal-Weight | maintained | $28.41 | $32 | replaced 2026-04-08, new $34 | +36.9% |
| 2026-02-25 | Morgan Stanley | Equal-Weight | maintained | $20.77 | $25 | reached 2026-02-27 | -7.2% |
| 2026-02-18 | JPMorgan | Overweight | maintained | $21.42 | $36 | replaced 2026-04-16, new $35 | -12.0% |
| 2026-02-18 | Barclays | Overweight | maintained | $21.42 | $35 | replaced 2026-07-09, new $31 | -12.0% |
| 2026-02-18 | Truist Securities | Buy | maintained | $21.42 | $29 | reached 2026-03-11 | -12.0% |
| 2026-02-18 | Citizens | Market Outperform | maintained | $21.42 | $34 | replaced 2026-04-29, new $35 | -12.0% |
| 2026-02-18 | Stifel | Buy | maintained | $21.42 | $36 | replaced 2026-04-29, new $35 | -12.0% |
| 2026-02-18 | Macquarie | Outperform | maintained | $21.42 | $32 | replaced 2026-04-29, new $34 | -12.0% |
| 2026-01-21 | TD Cowen | Buy | maintained | $23.53 | $35 | replaced 2026-07-29, new $31 | -6.0% |
| 2026-01-16 | Morgan Stanley | Equal-Weight | maintained | $24.35 | $27 | replaced 2026-02-25, new $25 | +2.5% |
| 2026-01-08 | Susquehanna | Neutral → Positive | upgrade | $25.07 | $31 | replaced 2026-04-29, new $34 | +7.6% |
| 2025-12-15 | Goldman Sachs | Buy → Neutral | downgrade | $24.01 | $24 | within 5% of price when set | +21.4% |
| 2025-11-21 | Citigroup | Neutral | initiated | $21.32 | $23 | reached 2025-11-28 | — |
| 2025-11-18 | Wells Fargo | Equal-Weight | initiated | $20.35 | $21 | within 5% of price when set | — |
| 2025-11-04 | Jefferies | Buy → Hold | downgrade | $20.02 | $22 | reached 2025-11-25 | — |
| 2025-10-29 | Macquarie | Outperform | maintained | $18.73 | $33 | replaced 2026-02-18, new $32 | — |
| 2025-10-29 | Goldman Sachs | Buy | maintained | $18.73 | $25 | replaced 2025-12-15, new $24 | — |
| 2025-10-29 | Stifel | Buy | maintained | $18.73 | $37 | replaced 2026-02-18, new $36 | — |
| 2025-10-29 | Citizens | Market Outperform | maintained | $18.73 | $37 | replaced 2026-02-18, new $34 | — |
| 2025-10-29 | JPMorgan | Overweight | maintained | $18.73 | $38 | replaced 2026-02-18, new $36 | — |
| 2025-10-29 | Truist Securities | Buy | maintained | $18.73 | $30 | replaced 2026-02-18, new $29 | — |
Also in Sportsbooks & iGaming
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.